Skip to main content
Figure 3 | Journal of Clinical Movement Disorders

Figure 3

From: Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials

Figure 3

Percentage of responders on the investigator-rated CGI-I in DA-naive vs DA-exposed patients (week 12). Response on the CGI-I was defined as “much” or “very much” improved at week 12. CGI-I, Clinical Global Impression–Improvement; CI, confidence interval; DA, dopamine agonist; GEn, gabapentin enacarbil; OR, odds ratio.

Back to article page

Journal of Clinical Movement Disorders

ISSN: 2054-7072

Contact us